Announcements Trials
Browse Landscape

Phase

Phase 2 36Phase 1/2 9Phase 4 4Phase NA 3Phase 3 3Phase 1 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 3Stomach Neoplasms 1MSS Metastatic Colorectal Cancer 1Carcinoma, Renal Cell 1

Interventions

Colonoscopy 44Standard of Care 29Early Intervention, Educational 23Methods 22Blood Specimen Collection 21Exercise 20Educational Status 19Interviews as Topic 13Surveys and Questionnaires 12Practice Guidelines as Topic 12Patient Navigation 12Counseling 12Endoscopic Mucosal Resection 10Drug Therapy 10Oxaliplatin 9Irinotecan 8Fluorouracil 8Surgical Procedures, Operative 7Preoperative Exercise 7Lidocaine 7Bevacizumab 7Therapeutics 6Resistance Training 6Occult Blood 6Narrow Band Imaging 6Mass Screening 6Leucovorin 6Diet 6Decision Support Techniques 6Control Groups 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Colorectal Neoplasms × HMPL-013 × Clear all
NCT07124858 2026-05-26

COFRUQ

Federation Francophone de Cancerologie Digestive

Phase NA Recruiting
300 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06985316 2025-05-22

An Exploratory Clinical Study Evaluating the Efficacy and Safety of Tunlametinib Combined With Fruquintinib in the Third-line Treatment of Advanced Colorectal Cancer Patients With RAS Mutations.

Tongji Hospital

Phase NA Not yet recruiting
34 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06551207 2024-08-13

Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC

Tongji Hospital

Phase NA Recruiting
80 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡